Future of Bioresorbable Vascular Scaffolds Market (2026-2033) | Drug-Eluting Scaffolds, Coronary Artery Disease Treatment, PLLA Materials & Minimally Invasive Cardiology Growth | Top Companies 2026 - Abbott, Boston Scientific, BIOTRONIK

Market Size and Growth 2026

Global Bioresorbable Vascular Scaffolds Market is expected to reach at a High CAGR during the forecast period 2026-2033.

DataM Intelligence has released a new research report titled Bioresorbable Vascular Scaffolds Market Size 2026 The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Bioresorbable Vascular Scaffolds market.

Ready to scale in the Bioresorbable Vascular Scaffolds Market? Connect with the right partners and unlock new growth opportunities today:- https://www.datamintelligence.com/partner-identification-enquiry/bioresorbable-vascular-scaffolds-market?sb

Key Developments 2025-2026:

United States: Recent Industry Developments

✅ In March 2026, Abbott Laboratories advanced clinical research on next-generation bioresorbable vascular scaffolds with improved resorption timelines and enhanced vessel healing performance. The study focuses on reducing long-term complications associated with permanent stents. It strengthens Abbott's innovation in minimally invasive cardiovascular treatments.

✅ In February 2026, Boston Scientific invested in R&D programs for bioresorbable scaffold technologies aimed at improving flexibility and radial strength. The initiative targets better patient outcomes in complex coronary artery disease cases. It enhances the company's position in advanced interventional cardiology solutions.

✅ In January 2026, Elixir Medical announced progress in clinical trials for its drug-eluting bioresorbable scaffold platform designed for controlled drug release and faster healing. The technology focuses on reducing restenosis rates in patients. It supports the expansion of next-generation bioresorbable therapies.

✅ In January 2026, Reva Medical reported continued development of its bioresorbable scaffold system with enhanced structural integrity and imaging visibility. The platform aims to improve precision during implantation procedures. It contributes to advancements in bioresorbable cardiovascular devices.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):- https://www.datamintelligence.com/download-sample/bioresorbable-vascular-scaffolds-market?sb

Japan: Recent Industry Developments

✅ In March 2026, Terumo Corporation advanced development of bioresorbable vascular scaffolds with improved deliverability and vessel compatibility. The innovation focuses on enhancing safety and long-term patient outcomes. It supports Japan's leadership in interventional cardiology technologies.

✅ In February 2026, Asahi Intecc invested in expanding its capabilities for bioresorbable scaffold delivery systems and catheter technologies. The initiative aims to improve procedural efficiency and device precision. It strengthens integration of advanced cardiovascular solutions.

✅ In January 2026, Kaneka Corporation progressed in material innovation for bioresorbable scaffolds using advanced polymer technologies. The development enhances scaffold degradation control and biocompatibility. It supports next-generation bioresorbable device manufacturing.

✅ In January 2026, Nipro Corporation expanded its cardiovascular product portfolio with focus on bioresorbable scaffold-related technologies. The initiative targets minimally invasive treatment solutions for coronary artery disease. It aligns with Japan's growing demand for advanced cardiac care.

List of Major Key Players 2026:

=> BIOTRONIK, REVA Medical, Arterius, Meril Life Sciences Pvt. Ltd, Zorion Medical, Translumina, Abbott, Boston Scientific Corporation, Nano Therapeutics, Tsuna Med and among others.

Request Strategic Market Customization: https://datamintelligence.com/customize/bioresorbable-vascular-scaffolds-market?sb

Growth Forecast Projection 2026:

The Global Bioresorbable Vascular Scaffolds Market is anticipated to rise at a considerable rate during the forecast period, between 2026 and 2033. In 2025, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

How Our Market Research Process Works:

The global Bioresorbable Vascular Scaffolds Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including government regulations, evolving market dynamics, competitive intensity, and historical performance trends. It also analyzes technological advancements, emerging innovations, and developments across related industries. In addition, the report assesses market volatility, growth opportunities, potential barriers, and key challenges that could impact the future expansion of the Bioresorbable Vascular Scaffolds ecosystem.

Recent Mergers & Acquisitions (M & A) 2025-2026:

✅ In April 2026, Abbott Laboratories expanded its structural heart and vascular portfolio strategy, with continued investments and partnerships focused on next-generation bioresorbable vascular scaffold (BVS) technologies aimed at improving long-term patient outcomes and reducing permanent implant risks.

✅ In April 2026, Biotronik strengthened its interventional cardiology pipeline through strategic collaborations and technology integration initiatives targeting advanced resorbable scaffold platforms and minimally invasive treatments.

✅ In March 2026, Elixir Medical entered into strategic partnership and licensing discussions to expand commercialization of its DESolve® bioresorbable scaffold, focusing on global market penetration and regulatory expansion.

✅ In February 2026, Reva Medical progressed strategic restructuring and asset optimization efforts, opening opportunities for potential acquisition or partnerships in the bioresorbable scaffold segment as the company focuses on next-gen coronary scaffold technologies.

✅ In February 2026, Boston Scientific increased investment and scouting for acquisition targets in bioresorbable technologies, aiming to re-enter the BVS market with improved safety and efficacy profiles following earlier-generation setbacks.

Unlock Full 360° Strategic Report: https://www.datamintelligence.com/buy-now-page?report=bioresorbable-vascular-scaffolds-market?sb

Major Focused Key Segmentations 2026:

➥ By Device Type: Everolimus-Eluting Device, Novolimus-Eluting Device, Sirolimus-Eluting Device

➥ By Application: Coronary Artery Disease, Peripheral Artery Disease

➥ By Material Type: Poly-L-Lactic Acid (PLLA), Tyrosine-Derived Polycarbonate, Others

➥ By End-User: Hospitals, Ambulatory Surgical Centers, Cardiac Catheterization Labs, Others

➥ By Region: North America, Latin America, Europe, Asia Pacific, Middle East, Africa - Share, Size, Outlook, and Opportunity Analysis (2026-2033)

Regional Growth Analysis for Market:

⇥ North America: Leads the Bioresorbable Vascular Scaffolds market with strong R&D investments, advanced material innovation, and growing adoption across electronics, energy storage, and aerospace sectors.

⇥ Asia-Pacific (including Japan): Dominates global demand, driven by large-scale production, expanding applications in electronics, batteries, and industrial manufacturing across China, Japan, and India.

⇥ Europe: Significant growth supported by government-funded research initiatives, sustainability focus, and increasing use in automotive and renewable energy applications.

⇥ Middle East & Africa: Emerging market fueled by rising interest in advanced materials, infrastructure development, and early-stage adoption in energy and construction sectors.

We Provide Benefits of the Report:

Chapter 1: Lays the foundation by defining the scope of the report, highlighting core market segments across regions, product types, and applications. It delivers a clear snapshot of current market size, growth potential, and how the industry is expected to evolve in both the near and long term.

Chapter 2: Spotlights the most impactful market insights, unveiling the transformative trends and forces shaping the future of the industry.

Chapter 3: Provides a deep dive into the competitive landscape of , covering revenue shares, strategic initiatives, and notable mergers & acquisitions that are reshaping the market.

Chapter 4: Presents detailed company profiles of leading players featuring financial performance, product portfolios, profit margins, and key milestones that set them apart in the industry.

Chapters 5 & 6: Break down revenue analysis at both regional and country levels, offering precise data on market size, growth drivers, and expansion opportunities across global markets.

Chapter 7: Analyzes the market by product type, spotlighting segment-specific opportunities and helping stakeholders identify untapped, high-growth areas.

Chapter 8 :Explores the market through application-based segmentation, assessing demand across industries and pinpointing downstream sectors with the strongest potential for growth.

Chapter 9: Maps the industry's supply chain in detail, tracing upstream and downstream activities to provide clarity on value creation across the ecosystem.

Chapter 10: Wraps up with a concise summary of the report's key insights distilling the most critical findings and strategic takeaways for decision-makers and stakeholders.

Get Unlimited Market Reports & Strategic Insights: https://www.datamintelligence.com/reports-subscription

Contact:
Fabian
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda, Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
UK: +44 161-870-5507
Email: fabian@datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.